These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma. Horvai AE, DeVries S, Roy R, O'Donnell RJ, Waldman F. Mod Pathol; 2009 Nov; 22(11):1477-88. PubMed ID: 19734852 [Abstract] [Full Text] [Related]
9. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases. Ricciotti RW, Baraff AJ, Jour G, Kyriss M, Wu Y, Liu Y, Li SC, Hoch B, Liu YJ. Cancer Genet; 2017 Dec; 218-219():69-80. PubMed ID: 29153098 [Abstract] [Full Text] [Related]
11. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma. Lee SE, Kim YJ, Kwon MJ, Choi DI, Lee J, Cho J, Seo SW, Kim SJ, Shin YK, Choi YL. Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861 [Abstract] [Full Text] [Related]
12. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma. Chung L, Lau SK, Jiang Z, Loera S, Bedel V, Ji J, Weiss LM, Chu PG. Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885 [Abstract] [Full Text] [Related]
14. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration. Mariño-Enríquez A, Hornick JL, Dal Cin P, Cibas ES, Qian X. Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706 [Abstract] [Full Text] [Related]